Poseida Therapeutics Inc 2RZ.SG
$8.93
Last Updated: Jan 07, 12:00 AM·XSTU
Pricing for DE stocks is delayed by 24 hours
2RZ.SG Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Poseida Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Poseida Therapeutics Inc. Stock Analysis 2RZ.SG
Germany Health Care Small Cap Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. The company is headquartered in San Diego, California and currently employs 350 full-time employees. The company went IPO on 2020-07-10. Its pipeline includes allogeneic CAR-T cell therapy product candidates for both solid and liquid tumors, as well as in vivo gene therapy product candidates that address patient populations with high unmet medical need. Its approach to cell and gene therapies is based on its proprietary genetic editing platforms, including its non-viral piggyBac DNA Delivery System, Cas-CLOVER Site-Specific Gene Editing System, Booster Molecule and nanoparticle and hybrid gene delivery technologies, as well as in-house GMP cell therapy manufacturing. Its lead programs, including P-FVIII-101, a non-viral approach. Its product candidate P-BCMA-ALLO1 and P-BCMACD19-ALLO1 is developed for patients with multiple myeloma. P-BCMA-ALLO1 is in a Phase I trial, being developed for patients with relapsed/refractory multiple myeloma.
Poseida Therapeutics Inc (2RZ.SG) Chart
Financial Metrics & Statements of Poseida Therapeutics Inc (2RZ.SG)
FAQ's for Poseida Therapeutics Inc (2RZ.SG)
- As of August 2026, Poseida Therapeutics Inc 2RZ.SG is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Poseida Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Poseida Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Poseida Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Poseida Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Poseida Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Poseida Therapeutics Inc (2RZ.SG)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
